VP
ELEV
venBio Partners’s Elevation Oncology ELEV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,434,255
| Closed | -$6.57M | – | 7 |
|
|
2024
Q2 | $6.57M | Sell |
2,434,255
-261,878
| -10% | -$707K | 2.84% | 6 |
|
|
2024
Q1 | $13.8M | Sell |
2,696,133
-218,122
| -7% | -$1.12M | 4.91% | 5 |
|
|
2023
Q4 | $1.56M | Hold |
2,914,255
| – | – | 0.23% | 6 |
|
|
2023
Q3 | $1.93M | Hold |
2,914,255
| – | – | 0.55% | 7 |
|
|
2023
Q2 | $4.43M | Buy |
2,914,255
+1,047,916
| +56% | +$1.59M | 1.6% | 6 |
|
|
2023
Q1 | $3.55M | Hold |
1,866,339
| – | – | 1.97% | 6 |
|
|
2022
Q4 | $1.77M | Hold |
1,866,339
| – | – | 0.55% | 7 |
|
|
2022
Q3 | $2.11M | Hold |
1,866,339
| – | – | 0.49% | 8 |
|
|
2022
Q2 | $2.61M | Sell |
1,866,339
-741,828
| -28% | -$1.04M | 0.74% | 8 |
|
|
2022
Q1 | $6.57M | Hold |
2,608,167
| – | – | 1.46% | 9 |
|
|
2021
Q4 | $15.7M | Hold |
2,608,167
| – | – | 2.83% | 7 |
|
|
2021
Q3 | $20.3M | Hold |
2,608,167
| – | – | 2.02% | 6 |
|
|
2021
Q2 | $35.4M | Buy |
+2,608,167
| New | +$35.4M | 4.18% | 5 |
|